Earnings History Data for Karyopharm Therapeutics Inc. (KPTI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
29-02-2024	PM		KPTI	Karyopharm Therapeutics Inc.	150.04	-0.36	-0.29	-0.43	Karyopharm Therapeutics GAAP EPS of -$0.36 misses by $0.07, revenue of $33.7M beats by $0.08M [2/29/2024 7:33 AM]	1.14	-0.19 (-14.29%)	1.33	0.0 (0.00%)	0.62 - 4.87	2,808,841	1,650,000	39,830
Karyopharm Therapeutics Q4 2023 Earnings Preview [2/28/2024 10:48 AM] Karyopharm Therapeutics GAAP EPS of -$0.36 misses by $0.07, revenue of $33.7M beats by $0.08M [2/29/2024 7:33 AM]
02-11-2023	PM		KPTI	Karyopharm Therapeutics Inc.	99.49	-0.30	-0.28	-0.45	Karyopharm Therapeutics GAAP EPS of -$0.30 misses by $0.05, revenue of $36M misses by $1.4M [11/2/2023 7:33 AM]	0.7613	-0.02 (-3.17%)	0.76	0.0 (0.00%)	0.75 - 5.97	1,810,550	1,170,000	4,022
Karyopharm Therapeutics Q3 2023 Earnings Preview [11/1/2023 1:57 PM] Karyopharm Therapeutics GAAP EPS of -$0.30 misses by $0.05, revenue of $36M misses by $1.4M [11/2/2023 7:33 AM]
02-08-2023	PM		KPTI	Karyopharm Therapeutics Inc.	205.22	-0.29	-0.34	-0.62	Karyopharm Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $37.6M beats by $1.93M [8/2/2023 7:43 AM]	1.79	-0.01 (-0.28%)	1.86	0.06 (3.33%)	1.44 - 6.01	2,009,977	3,070,000	129,185
Karyopharm Therapeutics Q2 2023 Earnings Preview [8/1/2023 1:18 PM] Karyopharm Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $37.6M beats by $1.93M [8/2/2023 7:43 AM]
04-05-2023	PM	Before the open (May 4)	KPTI	Karyopharm Therapeutics Inc.	407.96	-0.30	-0.34	-0.53	Karyopharm Therapeutics GAAP EPS of -$0.30 beats by $0.08, revenue of $38.7M beats by $1.49M [5/4/2023 9:27 AM]	2.77	-0.90 (-24.45%)	3.43	-0.23 (-6.28%)	2.45 - 6.98	9,239,300	2,120,000	35,450
Karyopharm Therapeutics GAAP EPS of -$0.30 beats by $0.08, revenue of $38.7M beats by $1.49M [5/4/2023 9:27 AM] Karyopharm hits four-month low after guidance cut [5/4/2023 12:56 PM]
15-02-2023	PM	Before the open (Feb 15)	KPTI	Karyopharm Therapeutics Inc.	366.81	-0.43	-0.34	0.46	Karyopharm Therapeutics reports Q4 earnings miss; initiates FY23 outlook [2/15/2023 7:33 AM]	3.67	0.35 (10.54%)	3.29	-0.03 (-0.90%)	2.45 - 14.73	4,672,009	1,890,000	1,246
Karyopharm Therapeutics Q4 2022 Earnings Preview [2/14/2023 1:55 PM] Karyopharm Therapeutics reports Q4 earnings miss; initiates FY23 outlook [2/15/2023 7:33 AM]
03-11-2022	PM	4:05 PM ET (Nov 3)	KPTI	Karyopharm Therapeutics Inc.	375.89	-0.45	-0.56	-0.69		4.54	-0.21 (-4.52%)	4.56	-0.20 (-4.20%)	4.00 - 14.73	1,756,570	1,660,000	1,527
Karyopharm Therapeutics Q3 2022 Earnings Preview [11/2/2022 5:35 PM] Karyopharm Announces New Selinexor Data in Myelofibrosis and Multiple Myeloma to be Presented at ASH 2022 [Nov-03-22 09:18AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	KPTI	Karyopharm Therapeutics Inc.	353.41	-0.62	-0.63	-0.71	Karyopharm Therapeutics GAAP EPS of -$0.62 misses by $0.01, revenue of $39.68M beats by $3.72M [8/4/2022 7:40 AM]	4.51	0.02 (0.33%)	4.40	-0.10 (-2.22%)	4.00 - 14.73	2,715,927	1,850,000	100,253
Karyopharm Therapeutics Q2 2022 Earnings Preview [8/3/2022 12:28 PM] Karyopharm Therapeutics GAAP EPS of -$0.62 misses by $0.01, revenue of $39.68M beats by $3.72M [8/4/2022 7:40 AM] Karyopharm Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress [Aug-04-22 07:30AM]
05-05-2022	PM	7:35 AM ET (May 5)	KPTI	Karyopharm Therapeutics Inc.	501.92	-0.53	-0.63	-0.77	Karyopharm Therapeutics GAAP EPS of -$0.53 beats by $0.14, revenue of $47.67M beats by $13.26M [5/5/2022 7:12 AM]	6.72	0.07 (0.98%)	6.70	0.04 (0.60%)	4.42 - 14.73	4,800,525	3,714,814	5,169
Karyopharm Therapeutics Q1 2022 Earnings Preview [5/4/2022 3:00 PM] Karyopharm Therapeutics GAAP EPS of -$0.53 beats by $0.14, revenue of $47.67M beats by $13.26M [5/5/2022 7:12 AM] Karyopharm Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress [May-05-22 07:00AM] Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 09:05AM]
08-02-2022	PM	7:00 AM ET (Feb 8)	KPTI	Karyopharm Therapeutics Inc.	682.95	0.46	-0.40	-0.59	Karyopharm TherapeuticsEPS of $0.46, revenue of $126.2M beats by $94.28M [2/8/2022 7:39 AM]	8.19	-2.05 (-20.02%)	8.55	-1.69 (-16.50%)	4.42 - 17.39	7,624,531	2,770,000	383,422
Karyopharm Therapeutics Q4 2021 Earnings Preview [2/7/2022 1:05 PM] Karyopharm TherapeuticsEPS of $0.46, revenue of $126.2M beats by $94.28M [2/8/2022 7:39 AM] Karyopharm falls 13% following late-stage results on selinexor for endometrial cancer [2/8/2022 9:00 AM] Why Earnings Season Could Be Great for Karyopharm (KPTI) [Feb-07-22 08:32AM] Karyopharm Announces Phase 3 SIENDO Study Meets Primary Endpoint with Statistically Significant Increase in Progression-Free Survival in Patients with Advanced or Recurrent Endometrial Cancer [Feb-08-22 07:30AM] Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress [Feb-08-22 07:35AM] Investors in Karyopharm Therapeutics (NASDAQ:KPTI) from a year ago are still down 37%, even after 15% gain this past week [Feb-08-22 07:39AM] Karyopharm Therapeutics (KPTI) Tops Q4 Earnings and Revenue Estimates [Feb-08-22 08:55AM] Why Karyopharm Therapeutics Stock Is Falling Today [Feb-08-22 01:27PM] Karyopharm Therapeutics (KPTI) Q4 2021 Earnings Call Transcript [Feb-08-22 06:00PM]
03-11-2021	PM	7:00 AM ET (Nov 3)	KPTI	Karyopharm Therapeutics Inc.	439.39	-0.69	-0.68	-0.73	Karyopharm Therapeutics EPS misses by $0.01, beats on revenue [11/3/2021 7:02 AM]	7.99	2.21 (38.24%)	6.04	0.26 (4.50%)	4.42 - 18.00	23,629,870	950,000	244,167
Karyopharm Therapeutics Q3 2021 Earnings Preview [11/2/2021 12:15 PM] Karyopharm Therapeutics EPS misses by $0.01, beats on revenue [11/3/2021 7:02 AM] Karyopharm climbs over 25% most since early 2020 after strong revenue beat [11/3/2021 11:27 AM] Karyopharm Reports Strong Third Quarter 2021 Financial Results and Provides Business Highlights [Nov-03-21 07:00AM] Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates [Nov-03-21 08:25AM] Karyopharm Therapeutics inc (KPTI) Q3 2021 Earnings Call Transcript [Nov-03-21 03:01PM]
05-08-2021	PM	7:05 AM ET (Aug 5)	KPTI	Karyopharm Therapeutics Inc.	583.47	-0.71	-0.72	-0.63	Karyopharm Therapeutics EPS beats by $0.03, misses on revenue [8/5/2021 7:06 AM]	5.93	-1.89 (-24.23%)	6.15	-1.67 (-21.36%)	5.76 - 18.00	6,214,630	970,000	334,951
Karyopharm Therapeutics EPS beats by $0.03, misses on revenue [8/5/2021 7:06 AM] Karyopharm Reports Business Highlights and Second Quarter 2021 Financial Results [Aug-05-21 07:00AM] Karyopharm Therapeutics inc (KPTI) Q2 2021 Earnings Call Transcript [Aug-05-21 08:00PM]
03-05-2021	PM	7:00 AM ET (May 3)	KPTI	Karyopharm Therapeutics Inc.	717.59	-0.77	-0.70	-0.78	Karyopharm Therapeutics EPS misses by $0.07, misses on revenue [5/3/2021 7:06 AM]	9.44	0.10 (1.07%)	9.24	-0.10 (-1.07%)	8.93 - 21.82	3,461,243	1,500,000	16,036
Karyopharm Therapeutics EPS misses by $0.07, misses on revenue [5/3/2021 7:06 AM] Despite strong XPOVIO sales growth, Karyopharm misses Q1 earnings estimates [5/3/2021 8:23 AM] Karyopharm Therapeutics, Inc. to Host Earnings Call [May-03-21 06:30AM] Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer [May-03-21 07:00AM] Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress [May-03-21 07:05AM] Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates [May-03-21 08:25AM] Karyopharm Therapeutics Inc (KPTI) Q1 2021 Earnings Call Transcript [May-03-21 04:30PM]
11-02-2021	PM	7:00 AM ET (Feb 11)	KPTI	Karyopharm Therapeutics Inc.	1,200	-0.59	-0.58	-0.76	Karyopharm Therapeutics EPS in-line, beats on revenue [2/11/2021 7:07 AM]	15.36	-0.51 (-3.21%)	15.90	0.03 (0.19%)	13.39 - 29.61	2,703,922	3,856,069	96,209
Karyopharm Therapeutics EPS in-line, beats on revenue [2/11/2021 7:07 AM] Karyopharm Q4 topline shines, expects XPOVIO sales growth [2/11/2021 7:51 AM] Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Misses Revenue Estimates [Feb-11-21 08:45AM] Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress [Feb-11-21 07:00AM] Karyopharm Therapeutics, Inc. to Host Earnings Call [Feb-11-21 06:30AM]
02-11-2020	AH	7:00 AM ET (Nov 2)	KPTI	Karyopharm Therapeutics Inc.	1,150	-0.73	-0.73	-0.67	Karyopharm Therapeutics EPS beats by $0.01, beats on revenue [11/2/2020 4:17 PM]	14.35	-0.15 (-1.03%)	15.00	0.50 (3.45%)	13.10 - 29.61	3,201,808	1,257,302	26,798

04-08-2020	PM	7:00 AM ET (Aug 4)	KPTI	Karyopharm Therapeutics Inc.	1,170	-0.63	-0.57	-0.71	Karyopharm Therapeutics EPS misses by $0.08, beats on revenue [8/4/2020 7:03 AM]	16.06	-0.80 (-4.74%)	16.65	-0.21 (-1.25%)	7.55 - 29.61	2,374,242	1,451,295	11,353

05-05-2020	PM	7:00 AM ET (May 5)	KPTI	Karyopharm Therapeutics Inc.	1,410	-0.78	-0.70	-1.09	Karyopharm Therapeutics EPS misses by $0.07, misses on revenue [5/5/2020 7:04 AM]	19.32	-1.36 (-6.55%)	19.30	-1.38 (-6.67%)	4.26 - 29.61	1,406,308	1,295,699	75,895